Rejected at 12:33 a.m. Nov, 01, 2023 ] by dollajas
Author: VerifiedSmoothBrain
Related Note: 1463845215297
Rationale for change

I meant to state in the rationale that Demeclocycline can induce Nephrogenic Diabetes Insipidous in addition to bone and teeth abnormalities.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042094/

Text Text
Extra
Empty field
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize


Physeo

OME

Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#SketchyPharm::07_Antimicrobials::02_Inhibitors_of_Bacterial_Protein_Synthesis::01_Tetracyclines #AK_Step1_v12::^Other::^HighYield::2-RelativelyHighYield #AK_Step1_v12::#Pixorize::03_Pharmacology::09_Other_Endocrine_Pharm::04_Demeclocycline #AK_Step1_v12::#FirstAid::08_Endocrine::05_Pharm::04_Hypothalamic/pituitary_drugs::*SIADH_Treatment !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#FirstAid::05_Pharm::03_Toxicities_and_Adverse_Effects::08_Drug_reactions-musculoskeletal/skin/connective_tissue #AK_Step1_v12::#SketchyPharm::05_GI_&_Endocrine::04_Hypothalamic_&_Pituitary::02_ADH,_DDAVP,_ADH_receptor_antagonists #AK_Step1_v12::#OME::PreClinical::Endocrine #AK_Step1_v12::#FirstAid::08_Endocrine::05_Pharm::04_Hypothalamic/pituitary_drugs::*Demeclocycline #AK_Step2_v12::#B&B::08_Infectious_Disease::01_Antibiotics::03_Protein_Synthesis_Inhibitors #AK_Step1_v12::#B&B::13_Infectious_Disease::03_Antibiotics::04_Protein_Synthesis_Inhibitors #AK_Step1_v12::#Bootcamp::Microbiology::36_Antibiotics::13_Tetracyclines_and_Derivatives #AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#Physeo::09_Pharm::07_Endocrine::13_ADH-Related_Drugs #AK_Step1_v12::^Systems::Endocrine::Pharmacology #AK_Step1_v12::#AMBOSS::nca71j #AK_Step1_v12::#AMBOSS::T3a634